Cited by 298Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study.

Open access

Asztalos, Bela F., Cupples, L. Adrienne, Demissie, Serkalem, Horvath, Katalin V., Cox, Caitlin E., Batista, Marcelo C., Schaefer, Ernst J.·2004·Arteriosclerosis, Thrombosis, and Vascular Biology

DOI 10.1161/01.atv.0000146325.93749.a8

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: High-density lipoprotein (HDL) is a heterogeneous lipoprotein class and there is no consensus on the value of HDL subspecies in coronary heart disease (CHD) risk assessment. We tested the hypothesis whether specific HDL subpopulations are significantly associated with CHD-prevalence. METHODS AND RESULTS: ApoA-I concentrations (mg/dL) in HDL subpopulations were quantitatively determined by native 2d gel electrophoresis, immunoblotting, and image analysis in male participants in the Framingham Offspring Study (FOS). CHD cases (n=169) had higher prebeta-1 and alpha-3 particle and lower alpha-1, prealpha-3, and prealpha-1 particle levels than either all (n=1277) or HDL cholesterol-matched (n=358) controls. alpha-1 and prealpha-3 levels had an inverse association, whereas alpha-3 and prealpha-1 particle levels had a positive association with CHD prevalence after adjusting the data for established CHD risk factors. Standardized logit coefficients indicated that alpha-1 HDL was most significantly associated with CHD prevalence. Moreover, each mg/dL increase in alpha-1 particle level decreased odds of CHD by 26% (P<0.0001), whereas each mg/dL increase in HDL cholesterol decreased odds of CHD by 2% in a model including all established CHD risk factors. CONCLUSIONS: Specific HDL subpopulations were positively correlated, whereas others were inversely correlated with CHD prevalence in male subject in the FOS, indicating that the various HDL particles might have different roles in the cause of CHD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.atv.0000146325.93749.a8

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes: A Randomized Controlled Trial
Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2292 · Cited by 1,707
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639
Molecular physiology of reverse cholesterol transport.
Fielding, C. J., & Fielding, P. E. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39898-9 · Cited by 1,448
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108083250601 · Cited by 1,163
The Framingham Offspring Study
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Springer eBooks · doi:10.1007/978-3-642-95642-3_25 · Cited by 832
Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoprotein
Castro, G. R., & Fielding, C. J. (1988) · Biochemistry · doi:10.1021/bi00401a005 · Cited by 641
Autoradiography using storage phosphor technology
Johnston, R. F., Pickett, S. C., & Barker, D. L. A. (1990) · Electrophoresis · doi:10.1002/elps.1150110503 · Cited by 525
Apolipoprotein A-I containing lipoproteins in coronary artery disease
Puchois, P., Kandoussi, A., Fievet, P., Fourrier, J. L., Bertrand, M. E., Koren, E., & Fruchart, J. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90091-8 · Cited by 326
Two-dimensional electrophoresis of plasma lipoproteins: Recognition of new apo A-I-containing subpopulations
Asztalos, B. F., Sloop, C. H., Wong, L., & Roheim, P. S. (1993) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(93)90253-6 · Cited by 235
Self-citation
A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.
Parra, H. J., Arveiler, D., Evans, A. E., Cambou, J., Amouyel, P., Bingham, A., McMaster, D., Schaffer, P., DOUSTE‐BLAZY, P., & Luc, G. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.6.701 · Cited by 232

Show all 30 references

Research works printed but not linked: 7

10.1161/circ.90.2.8044946 · DOI
10.1161/circ.85.1.1728453 · DOI
10.1161/atvb.20.12.2670 · DOI
10.1161/atvb.17.10.1885 · DOI
1996, Clin Chem, 42, 12;1992
10.1161/circ.100.6.594 · DOI
10.1161/atvb.21.8.1320 · DOI

Sorted by citations

Items 101–200 of 298

The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia
Nakou, E., Filippatos, T. D., Kiortsis, D. N., Derdemezis, C. S., Tselepis, A. D., Mikhailidis, D. P., & Elisaf, M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802548430 · Cited by 35
Effects of cholesteryl ester transfer protein inhibitors on human lipoprotein metabolism
Schaefer, E. J. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283612454 · Cited by 34
Self-citation
Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation?
Rádiková, Ž., Penesová, A., Vlček, M., Havranová, A., Siváková, M., Šiarnik, P., Žitňanová, I., Imrich, R., Turčáni, P., & Kollár, B. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01221-x · Cited by 34
Nanotechnology for synthetic high-density lipoproteins
Luthi, A. J., Patel, P. C., Ko, C. H., Mutharasan, R. K., Mirkin, C. A., & Thaxton, C. S. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.10.006 · Cited by 35
A nutrient‐dense, high‐fiber, fruit‐based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2‐wk trial
Mietus‐Snyder, M., Shigenaga, M. K., Suh, J. H., Shenvi, S. V., Lal, A., McHugh, T. H., Olson, D., Lilienstein, J., Krauss, R. M., Gildengoren, G. L., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-201558 · Cited by 34
Apoprotein B, Small‐Dense LDL and Impaired HDL Remodeling Is Associated With Larger Plaque Burden and More Noncalcified Plaque as Assessed by Coronary CT Angiography and Intravascular Ultrasound With Radiofrequency Backscatter: Results From the ATLANTA I Study
Vörös, S., Joshi, P. H., Qian, Z., Rinehart, S. J., Figueroa, J. G. V., Anderson, H., Elashoff, M. R., Murrieta, L., Karmpaliotis, D., Kalynych, A. M., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000344 · Cited by 34
Self-citation
Alterations of high-density lipoprotein subclasses in endogenous hypertriglyceridemia
Gou, L., Fu, M., Xu, Y., Tian, Y., Yan, B., & Lu-chuan, Y. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.032 · Cited by 33
Genetic associations with lipoprotein subfractions provide information on their biological nature
Petersen, A.-K., Stark, K. J., Musameh, M. D., Nelson, C. P., Römisch‐Margl, W., Kremer, W., Raffler, J., Krug, S., Skurk, T., Rist, M. J., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr580 · Cited by 33
Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study
Filippatos, T. D., Derdemezis, C. S., Voulgari, P. V., Tsimihodimos, V., Elisaf, M., Tselepis, A. D., & Drosos, A. A. (2013) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2012.745013 · Cited by 32
Direct assessment of plasma low density lipoprotein and high density lipoprotein cholesterol levels and coronary heart disease: Results from the Framingham Offspring Study
Otokozawa, S., Ai, M., Asztalos, B. F., White, C. C., Demissie, S., Cupples, L. A., Nakajima, K., Wilson, P. W. F., & Schaefer, E. J. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.02.041 · Cited by 32
Self-citation
Prevalence of Emerging Cardiovascular Risk Factors in Younger Individuals with a Family History of Premature Coronary Heart Disease and Low Framingham Risk Score
Sailam, V., Karalis, D. G., Agarwal, A., Alani, F. R., Galardi, S., Covalesky, V. A., & Athanassious, C. N. (2008) · Clinical Cardiology · doi:10.1002/clc.20355 · Cited by 32
Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release
Hassan, H. H., Blain, S., Boucher, B., Denis, M., Krimbou, L., & Genest, J. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400477-jlr200 · Cited by 32
High-Density Lipoprotein Metabolism and Function in Cardiovascular Diseases: What about Aging and Diet Effects?
Morvaridzadeh, M., Zoubdane, N., Heshmati, J., Alami, M., Berrougui, H., & Khalil, A. (2024) · Nutrients · doi:10.3390/nu16050653 · Cited by 39
Pharmacokinetics, Metabolism, and Excretion of Anacetrapib, a Novel Inhibitor of the Cholesteryl Ester Transfer Protein, in Rats and Rhesus Monkeys
Tan, E. Y., Hartmann, G., Chen, Q., Pereira, A., Bradley, S. A., Doss, G. A., Zhang, A. S., Ho, J. Z., Braun, M. P., Dean, D. C., et al. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028696 · Cited by 31
Dose-dependent Effect of Rosuvastatin Treatment on HDL-subfraction Phenotype in Patients With Primary Hyperlipidemia
Kostapanos, M. S., Milionis, H. J., Filippatos, T. D., Christogiannis, L. G., Bairaktari, E. T., Tselepis, A. D., & Elisaf, M. (2009) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248408331031 · Cited by 30
Inclusion of Almonds in a Cholesterol-Lowering Diet Improves Plasma HDL Subspecies and Cholesterol Efflux to Serum in Normal-Weight Individuals with Elevated LDL Cholesterol
Berryman, C. E., Fleming, J. A., & Kris‐Etherton, P. M. (2017) · Journal of Nutrition · doi:10.3945/jn.116.245126 · Cited by 32
Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women
Furusyo, N., Ai, M., Okazaki, M., Ikezaki, H., Ihara, T., Hayashi, T., Hiramine, S., Ura, K., Kohzuma, T., Schaefer, E. J., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.09.008 · Cited by 30
Self-citation
Effects of Increasing Doses of Atorvastatin on the Atherogenic Lipid Subclasses Commonly Associated With Hypertriglyceridemia
Karalis, D. G., Ishisaka, D. Y., Luo, D., Ntanios, F. Y., & Wun, C. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.043 · Cited by 30
Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus erythematosus: a double-blind randomized clinical trial
Juárez-Rojas, J. G., Medina-Urrutia, A. X., Galarza, E. J., Caracas-Portilla, N., Posadas‐Sánchez, R., Cardoso-Saldaña, G. C., Goycochea-Robles, M., Silveira, L., Lino-Pérez, L., Mas‐Oliva, J., et al. (2011) · Lupus · doi:10.1177/0961203311422096 · Cited by 29
High-density lipoproteins are abnormal in young women with uncomplicated systemic lupus erythematosus
Juárez-Rojas, J. G., Medina-Urrutia, A. X., Posadas‐Sánchez, R., Galarza, E. J., Mendoza-Peŕez, E., Caracas-Portilla, N., Cardoso-Saldaña, G. C., Muñoz-Gallegos, G., & Posadas‐Romero, C. (2008) · Lupus · doi:10.1177/0961203308093072 · Cited by 29
Does simultaneous determination of LDL and HDL particle size improve prediction of coronary artery disease risk?
Zeljković, A., Spasojević‐Kalimanovska, V., Vekić, J., Jelić‐Ivanović, Z., Topić, A., Bogavac‐Stanojević, N., Spasić, S., Vujović, A., & Kalimanovska‐Oštrić, D. (2008) · Clinical and Experimental Medicine · doi:10.1007/s10238-008-0165-z · Cited by 29
Nicotinic acid and other therapies for raising high-density lipoprotein
Carlson, L. A. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000231404.76930.e9 · Cited by 29
HDL abnormalities in type 2 diabetes: Clinical implications
Martagón, A. J., Zubirán, R., González-Arellanes, R., Praget-Bracamontes, S., Rivera-Alcántara, J. A., & Aguilar-Salinas, C. A. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117213 · Cited by 30
High-density lipoproteins: Marker of cardiovascular risk and therapeutic target
Toth, P. P., & Davidson, M. H. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.08.002 · Cited by 28
N-terminal mutation of apoA-I and interaction with ABCA1 reveal mechanisms of nascent HDL biogenesis
Liu, M., Mei, X., Herscovitz, H., & Atkinson, D. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m084376 · Cited by 28
Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women
Lamon‐Fava, S., Herrington, D. M., Reboussin, D. M., Sherman, M., Horvath, K. V., Schaefer, E. J., & Asztalos, B. F. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.020 · Cited by 29
Self-citation
Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy
Toth, P. P. (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s22601 · Cited by 27
High-density lipoproteins for therapeutic delivery systems
Mutharasan, R. K., Foit, L., & Thaxton, C. S. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01332a · Cited by 28
Impact of Mifepristone, a Glucocorticoid/Progesterone Antagonist, on HDL Cholesterol, HDL Particle Concentration, and HDL Function
Page, S. T., Krauss, R. M., Gross, C., Ishida, B. Y., Heinecke, J. W., Tang, C., Amory, J. K., Schaefer, P. M., Cox, C. J., Kane, J. P., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2813 · Cited by 28
Self-citation
HDL Particle Measurement: Comparison of 5 Methods
Matera, R. M., Horvath, K. V., Nair, H., Schaefer, E. J., & Asztalos, B. F. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.277632 · Cited by 28
Self-citation
Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review
Chary, A., Tohidi, M., & Hedayati, M. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03578-0 · Cited by 28
Is Lipid Accumulation Product Associated with an Atherogenic Lipoprotein Profile in Brazilian Subjects?
Cartolano, F. D. C., Pappiani, C., de Freitas, M. C. P., Neto, A. M. F., Carioca, A. A. F., & Damasceno, N. R. T. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180054 · Cited by 24
Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome
Agouridis, A. P., Kostapanos, M. S., Tsimihodimos, V., Kostara, C. E., Mikhailidis, D. P., Bairaktari, E. T., Tselepis, A. D., & Elisaf, M. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02972.x · Cited by 25
Glycogen storage disease type Ia: Linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism
Sever, S., Weinstein, D. A., Wolfsdorf, J. I., Gedik, R., & Schaefer, E. J. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.08.005 · Cited by 25
Self-citation
Small High‐Density Lipoprotein (HDL) Subclasses are Increased with Decreased Activity of HDL‐Associated Phospholipase A2 in Subjects with Prediabetes
Filippatos, T. D., Rizos, E. C., Tsimihodimos, V., Gazi, I. F., Tselepis, A. D., & Elisaf, M. (2013) · Lipids · doi:10.1007/s11745-013-3787-1 · Cited by 27
The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial
Benatti, F. B., Miossi, R., Passareli, M., Nakandakare, E. R., Perandini, L. A., Lima, F. R., Roschel, H., Borba, E. F., Bonfá, E., Gualano, B., et al. (2014) · Rheumatology International · doi:10.1007/s00296-014-3081-4 · Cited by 26
A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier disease
Negi, S., Brautbar, A., Virani, S. S., Anand, A., Polisecki, E. Y., Asztalos, B. F., Ballantyne, C. M., Schaefer, E. J., & Jones, P. H. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.09.004 · Cited by 26
Self-citation
Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naïve Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir
Gotti, D., Cesana, B. M., Albini, L., Calabresi, A., Izzo, I., Focà, E., Motta, D., Bellagamba, R., Fezza, R., Narciso, P., et al. (2012) · HIV Clinical Trials · doi:10.1310/hct1305-245 · Cited by 25
Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature
Roshan, B., Ganda, O. P., DeSilva, R. N., Ganim, R. B., Ward, E., Haessler, S., Polisecki, E. Y., Asztalos, B. F., & Schaefer, E. J. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.07.002 · Cited by 25
Self-citation
Novel N-terminal mutation of human apolipoprotein A-I reduces self-association and impairs LCAT activation
Weers, P. M. M., Patel, A., Wan, L. C.-P., Guigard, E., Kay, C. M., Hafiane, A., McPherson, R., Marcel, Y. L., & Kiss, R. S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m007500 · Cited by 25
The relationship between adiponectin, an adiponectin gene polymorphism, and high-density lipoprotein particle size: from the Mima study
Tsuzaki, K., Kotani, K., Sano, Y., Fujiwara, S., Gazi, I. F., Elisaf, M., & Sakane, N. (2011) · Metabolism · doi:10.1016/j.metabol.2011.06.021 · Cited by 25
Markers of Systemic Inflammation and Apo-AI Containing HDL Subpopulations in Women with and without Diabetes
Russo, G. T., Giandalia, A., Romeo, E. L., Alibrandi, A., Horvath, K. V., Asztalos, B. F., & Cucinotta, D. (2014) · International Journal of Endocrinology · doi:10.1155/2014/607924 · Cited by 25
Self-citation
Arachidonate 5-Lipoxygenase Gene Variants Affect Response to Fish Oil Supplementation by Healthy African Americans
Armstrong, P., Kelley, D. S., Newman, J. W. I., Staggers, F. E., Hartiala, J., Allayee, H., & Stephensen, C. B. (2012) · Journal of Nutrition · doi:10.3945/jn.112.159814 · Cited by 23
The Value and Distribution of High-Density Lipoprotein Subclass in Patients with Acute Coronary Syndrome
Tian, L., Li, C., Liu, Y., Chen, Y., & Fu, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085114 · Cited by 24
A high-precision fluorogenic cholesteryl ester transfer protein assay compatible with animal serum and 3456-well assay technology
Eveland, S. S., Milot, D. P., Guo, Q., Chen, Y., Hyland, S. A., Peterson, L. B., Jezequel, S., O’Donnell, G. T., Zuck, P. D., Ferrer, M., et al. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.06.003 · Cited by 24
Understanding HDL Metabolism and Biology Through In Vivo Tracer Kinetics
Andraski, A. B., Sacks, F. M., Aikawa, M., & Singh, S. A. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319742 · Cited by 25
Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib
Hegele, R. A., & Goldberg (2012) · Drug Design Development and Therapy · doi:10.2147/dddt.s34976 · Cited by 24
Dietary omega-3 polyunsaturated fatty acid intake is related to a protective high-density lipoprotein subspecies profile independent of genetic effects: A monozygotic twin pair study
Bogl, L. H., Maranghi, M., Rissanen, A., Kaprio, J. A., Taskinen, M., & Pietiläinen, K. H. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.09.010 · Cited by 22
HDL drug carriers for targeted therapy
Liu, X., Suo, R., Xiong, S.-L., Zhang, Q., & Yi, G. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.10.008 · Cited by 22
Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status
Lamon‐Fava, S., Herrington, D. M., Horvath, K. V., Schaefer, E. J., & Asztalos, B. F. (2010) · Metabolism · doi:10.1016/j.metabol.2010.05.012 · Cited by 22
Self-citation
Benefits and Difficulties in Measuring HDL Subfractions and Human Paraoxonase-1 Activity During Statin Treatment
Harangi, M., Seres, I., Harangi, J., & Paragh, G. (2009) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-009-6205-4 · Cited by 22
Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia
Long, S., Tian, Y., Zhang, R., Yang, L., Xu, Y., Jia, L., & Fu, M. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.11.010 · Cited by 21
The impact of plasma triglyceride and apolipoproteins concentrations on high-density lipoprotein subclasses distribution
Tian, L., Xu, Y., Fu, M., Peng, T., Liu, Y., & Long, S. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-17 · Cited by 21
Essential Fatty Acid and Prostaglandin Metabolism in Sjögren’s Syndrome, Systemic Sclerosis and Rheumatoid Arthritis
Horrobin, D. F. (1986) · Scandinavian Journal of Rheumatology · doi:10.1080/15027732.1986.12461420 · Cited by 21
High Density Lipoprotein Particle Composition, Functionality, Deficiency, and Atherosclerotic Cardiovascular Disease Risk: A Review
Schaefer, E. J., Asztalos, B. F., Vaisar, T., Diffenderfer, M. R., Brewer, H. B., Stock, E. O., & Kane, J. P. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01308-9 · Cited by 20
Self-citation
A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease
Rani, A., & Marsche, G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051504 · Cited by 20
High-density lipoproteins in stroke.
Meilhac, O. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-09665-0_16 · Cited by 19
Characteristics of low-density and high-density lipoprotein subclasses in pediatric renal transplant recipients
Zeljković, A., Vekić, J., Spasojević‐Kalimanovska, V., Jelić‐Ivanović, Z., Peco‐Antić, A., Kostic, M., Vasić, D., & Spasić, S. (2011) · Transplant International · doi:10.1111/j.1432-2277.2011.01313.x · Cited by 19
New and Emerging Biomarkers in Cardiovascular Disease
Cahill, L. E., Bertoia, M. L., Aroner, S. A., Mukamal, K. J., & Jensen, M. K. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0661-y · Cited by 20
Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension
Christogiannis, L. G., Kostapanos, M. S., Tellis, C. C., Milionis, H. J., Tselepis, A. D., & Elisaf, M. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2011.108 · Cited by 19
Human serum preβ1-high density lipoprotein levels are independently and negatively associated with coronary artery diseases
Chen, Y., Dong, J., Chen, X., Jiang, H., Bakillah, A., Zhang, X., Li, Z., Yin, J., Liang, D., Zou, Y., et al. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0093-y · Cited by 19
Influence of menopause and cholesteryl ester transfer protein (CETP) TaqIB polymorphism on lipid profile and HDL subpopulations distribution in women with and without type 2 diabetes
Russo, G. T., Horvath, K. V., Benedetto, A. D., Giandalia, A., Cucinotta, D., & Asztalos, B. F. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.11.011 · Cited by 19
Self-citation
Laboratory investigation of dysfunctional HDL
Guo, Z. G., Li, C., Zhong, J. K., Tu, Y., & Xie, D. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.10.005 · Cited by 18
Carotid intima media thickness is related positively to plasma pre ß-high density lipoproteins in non-diabetic subjects
de Vries, R., Perton, F. G., van Tol, A., & Dullaart, R. P. F. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.11.001 · Cited by 18
Alterations of high-density lipoprotein subclasses in hypercholesterolemia and combined hyperlipidemia
Jia, L., Fu, M., Tian, Y., Xu, Y., Gou, L., Tian, H., & Tian, L. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.10.007 · Cited by 18
HDL deficiency due to a new insertion mutation (ApoA-INashua) and review of the literature
Lee, E. Y., Klementowicz, P. T., Hegele, R. A., Asztalos, B. F., & Schaefer, E. J. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.10.011 · Cited by 18
Self-citation
Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency
Alaupovic, P., Attman, P.-O., Knight‐Gibson, C., Mulec, H., Weiss, L. G., & Samuelsson, O. G. (2006) · Kidney International · doi:10.1038/sj.ki.5000327 · Cited by 18
Relationships between HDL subpopulation proteome and HDL function in overweight/obese people with and without coronary heart disease
Vaisar, T., Babenko, I., Horvath, K. V., Niisuke, K., & Asztalos, B. F. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118565 · Cited by 17
Self-citation
Lipoprotein Subfraction Profile and HDL‐Associated Enzymes in Sickle Cell Disease Patients
Öztürk, O. H., Can, Y., Yönden, Z., Motor, S., Oktay, G., Kaya, H., & Aslan, M. (2013) · Lipids · doi:10.1007/s11745-013-3849-4 · Cited by 17
An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in mice
Lu, S.-C., Atangan, L. I., Kim, K. W., Chen, M. M., Komorowski, R., Chu, C., Han, J., Hu, S., Gu, W., Véniant, M. M., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m020438 · Cited by 17
Plasma pre β-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein
Dallinga‐Thie, G. M., van Tol, A., & Dullaart, R. P. F. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.03.008 · Cited by 17
Pre-β1 HDL in type 2 diabetes mellitus
Shiu, S. W. M., Wong, Y., & Tan, K. C. B. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.05.031 · Cited by 17
High-density lipoprotein profile in newly-diagnosed lower extremity artery disease in Slovak population without diabetes mellitus.
Kasko, M., Gašpar, Ľ., Dukát, A., Gavorník, P., & Oravec, S. (2014) · PubMed · Cited by 17
High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes
Maddaloni, E., Xia, Y., Park, K., D’Eon, S., TINSLEY, L. J., St-Louis, R., Khamaisi, M., Li, Q., King, G. L., & Keenan, H. A. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0599-2 · Cited by 17
Native–Native 2D Gel Electrophoresis for HDL Subpopulation Analysis
Freeman, L. A. (2013) · Methods in molecular biology · doi:10.1007/978-1-60327-369-5_17 · Cited by 16
Effects of weight change on HDL-cholesterol and its subfractions in over 28,000 men and women
Dansinger, M. L., Williams, P. T., Superko, H. R., Asztalos, B. F., & Schaefer, E. J. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.12.001 · Cited by 16
Self-citation
Structural and Functional Analysis of the ApolipoproteinA-I A164S Variant
Dalla‐Riva, J., Lagerstedt, J. O., & Petrlová, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143915 · Cited by 16
The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity
Asztalos, B. F., Hauser, T. H., Goldfine, A. B., Welty, F. K., Horvath, K. V., & Schaefer, E. J. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.02.012 · Cited by 15
Self-citation
A Randomized Trial of ω-3 Fatty Acid Supplementation and Circulating Lipoprotein Subclasses in Healthy Older Adults
Moosavi, D., Vučković, I., Kunz, H., & Lanza, I. R. (2022) · Journal of Nutrition · doi:10.1093/jn/nxac084 · Cited by 15
The influence of apoE-deficiency and LDL-receptor-deficiency on the HDL subpopulation profile in mice and in humans
Tani, M., Matera, R. M., Horvath, K. V., Hasan, T. S., Schaefer, E. J., & Asztalos, B. F. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.080 · Cited by 15
Self-citation
Evacetrapib reduces preβ-1 HDL in patients with atherosclerotic cardiovascular disease or diabetes
Chen, Y., Dong, J., Zhang, X., Chen, X., Wang, L., Chen, H., Ge, J., & Jiang, X. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.04.211 · Cited by 16
Multidimensional profiling of plasma lipoproteins by size exclusion chromatography followed by reverse-phase protein arrays
Dernick, G., Obermüller, S., Mangold, C., Magg, C., Matile, H., Gutmann, O., von der Mark, E., Handschin, C., Maugeais, C., & Niesor, E. J. (2011) · Journal of Lipid Research · doi:10.1194/jlr.d016824 · Cited by 14
The association between dyslipidemia and anthropometric indicators in black and white adolescents residing in Tlokwe Municipality, North-West Province, South Africa: the PAHL study
Mamabolo, R., Sparks, M., Moss, S. J., & Monyeki, M. A. (2015) · African Health Sciences · doi:10.4314/ahs.v14i4.23 · Cited by 14
A multicomponent nutrient bar promotes weight loss and improves dyslipidemia and insulin resistance in the overweight/obese: chronic inflammation blunts these improvements
McCann, J. C., Shigenaga, M. K., Mietus‐Snyder, M., Lal, A., Suh, J. H., Krauss, R. M., Gildengorin, G. L., Goldrich, A., Block, D. S., Shenvi, S. V., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-271833 · Cited by 14
APOE genotype affects black-white responses of high-density lipoprotein cholesterol subspecies to aerobic exercise training
Obisesan, T. O., Ferrell, R. E., Goldberg, A. P., Phares, D. A., Ellis, T. J., & Hagberg, J. M. (2008) · Metabolism · doi:10.1016/j.metabol.2008.07.022 · Cited by 14
High density lipoprotein subfractions and paraoxonase 1 in children
Muchová, J., Andrezálová, L., Oravec, S., Garaiová, I., & Ďuračková, Z. (2016) · Acta Biochimica Polonica · doi:10.18388/abp.2015_1230 · Cited by 14
LDL and HDL lipoprotein subfractions in multiple sclerosis patients with decreased insulin sensitivity
Rádiková, Ž., Penesová, A., Vlček, M., Havranová, A., Siváková, M., Šiarnik, P., Žitňanová, I., Imrich, R., Kollár, B., & Turčáni, P. (2018) · Endocrine Regulations · doi:10.2478/enr-2018-0017 · Cited by 14
HDL: o yin-yang da doença cardiovascular
Leança, C. C., Passarelli, M., Nakandakare, E. R., & Quintão, E. C. R. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000900002 · Cited by 14
Where are we with high-density lipoprotein raising and inhibition of cholesteryl ester transfer for heart disease risk reduction?
Schaefer, E. J., & Asztalos, B. F. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3281fbd3c7 · Cited by 14
Self-citation
Anacetrapib: Hope for CETP Inhibitors?
Gurfinkel, R., & JOY, T. R. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00142.x · Cited by 13
Effects of Lipid-Lowering Drugs on High-Density Lipoprotein Subclasses in Healthy Men—A Randomized Trial
Berthold, H. K., Rizzo, M., Spenrath, N., Montalto, G., Krone, W., & Gouni‐Berthold, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091565 · Cited by 13
One third of the variability in HDL‐cholesterol level in a large dyslipidaemic population is predicted by age, sex and triglyceridaemia:The Paris La Pitié Study
Hansel, B., Kontush, A., Giral, P., Bonnefont‐Rousselot, D., Chapman, M. J., & Bruckert, É. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x104821 · Cited by 13
High-density lipoprotein cholesterol
Oda, M. N. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000139 · Cited by 14
Association of proportion of the HDL-cholesterol subclasses HDL-2b and HDL-3 and macrovascular events among patients undergoing hemodialysis
Lee, W., Chen, J., Moi, S., & Yang, C.-H. (2021) · Scientific Reports · doi:10.1038/s41598-021-81636-3 · Cited by 12
Defining the prevalence of low HDL-C in a European cohort of dyslipidaemic patients
Bruckert, É., Pamphile, R., McCoy, F., & André, P. (2005) · European Heart Journal Supplements · doi:10.1093/eurheartj/sui039 · Cited by 12
Effect of ezetimibe on low- and high-density lipoprotein subclasses in sitosterolemia
Othman, R. A., Myrie, S. B., Mymin, D., Roullet, J., Steiner, R. D., & Jones, P. J. H. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.03.015 · Cited by 12
High-density lipoprotein particles, coronary heart disease, and niacin
Asztalos, B. F. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.08.012 · Cited by 11
Self-citation
Characteristics of High-density Lipoprotein Subclasses Distribution for Subjects with Desirable Total Cholesterol Levels
Tian, L., Long, S., Fu, M., Liu, Y., Xu, Y., & Jia, L. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-64 · Cited by 11
HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation
Παπαγεωργίου, Ν., Zacharia, E. M., Androulakis, E. S., Briasoulis, Α., Charakida, M., & Tousoulis, D. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1152264 · Cited by 12
Novel Therapies for Increasing Serum Levels of HDL
Toth, P. P. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.11.012 · Cited by 11

Authors: Asztalos, B. F., Cupples, L. A., Demissie, S., Horvath, K. V., Cox, C. E., Batista, M. C., & Schaefer, E. J.
Affiliations: Boston University (US)
ORCID: Asztalos, Bela F.
Cupples, L. Adrienne
Demissie, Serkalem
Batista, Marcelo C.
Schaefer, Ernst J.
Venue: Arteriosclerosis, Thrombosis, and Vascular Biology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-11
Volume: 24
Issue: 11
Pages: 2181-2187
ISSN: 1079-5642 (ISSN-L)
1524-4636
DOI: 10.1161/01.atv.0000146325.93749.a8
OpenAlex: W2103507414
Cited by: 298
References: 30
Citations by year: 2025: 9 · 2024: 5 · 2023: 8 · 2022: 7 · 2021: 4 · 2020: 5 · 2019: 4 · 2018: 16 · 2017: 10 · 2016: 17 · 2015: 14 · 2014: 17 · 2013: 23 · 2012: 27
FWCI: 15.79
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01hc038038-022)
National Heart, Lung, and Blood Institute (HC 38038, HL54776, HL 64738, N01-HC, N01-HC-38038, R01HL054776, R01HL064738)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: high-density lipoprotein, HDL subpopulations, coronary artery disease, HDL cholesterol, apolipoprotein A-I, HDL heterogeneity, cardiovascular risk, Framingham Offspring Study, men
MeSH terms: Coronary Disease, Humans, Male, Prospective Studies, Risk Factors, Time, Prevalence, Apolipoprotein A-I, Observation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks